Earnings History Data for Monopar Therapeutics (MNPR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Monopar Therapeutics
Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2024 | PM | MNPR | Monopar Therapeutics | 63.00 | -0.37 | -0.46 | 0.00 | Monopar Therapeutics GAAP EPS of -$0.37 [11/8/2024 11:17 AM] |
16.63 | 0.90 (5.72%) |
17.00 | 1.27 (8.07%) |
1.37 - 38.50 | 145,087 | 850,000 | 3,048 | ||
| 10-11-2022 | PM | MNPR | Monopar Therapeutics | 56.00 | -0.19 | -0.23 | 0.00 | Monopar Therapeutics GAAP EPS of -$0.19 beats by $0.02 [11/10/2022 9:14 AM] |
3.24 | -1.15 (-26.20%) |
0.0 | 0.0 (0.00%) |
1.39 - 5.20 | 100,600 | 80,000 | 0 | ||
| 12-11-2021 | PM | MNPR | Monopar Therapeutics Inc. | 53.25 | -0.20 | -0.22 | -0.27 | Monopar Therapeutics EPS beats by $0.01 [11/12/2021 8:12 AM] |
5.00 | -0.01 (-0.20%) |
5.18 | 0.17 (3.39%) |
4.50 - 17.01 | 21,743 | 60,000 | 728 | ||
| 13-05-2021 | AH | After the close (May 13) |
MNPR | Monopar Therapeutics Inc. | 54.76 | -0.16 | -0.22 | -0.10 | Monopar Therapeutics EPS beats by $0.04 [5/13/2021 5:23 PM] |
5.22 | 0.17 (3.37%) |
5.25 | 0.09 (1.74%) |
4.28 - 17.01 | 13,542 | 20,000 | 250 | |
| 25-03-2021 | PM | MNPR | Monopar Therapeutics Inc. | 77.00 | -0.19 | -0.15 | 0.00 | Monopar Therapeutics EPS misses by $0.01 [3/25/2021 9:03 AM] |
6.28 | -0.44 (-6.55%) |
6.80 | 0.08 (1.19%) |
4.28 - 17.01 | 85,434 | 40,000 | 530 | ||
| 12-11-2020 | PM | MNPR | Monopar Therapeutics Inc. | 46.81 | -0.27 | -0.15 | 0.00 | Monopar Therapeutics EPS beats by $0.02 [11/12/2020 9:22 AM] |
4.90 | 0.22 (4.70%) |
5.00 | 0.32 (6.84%) |
4.28 - 48.00 | 60,767 | 16,664 | 300 | ||
|
|
||||||||||||||||||